The Market Opportunity
The potential market for non-invasive neurotech treatments is vast, encompassing a wide range of prevalent health conditions. Let's look at some key statistics that illustrate the scale of the opportunity:
Depression: According to the CDC, 5% of U.S. adults aged 18 and above report regular feelings of depression. Data from the U.S. National Center for Health Statistics shows that 13.2% of U.S. adults used antidepressant medications over a 30-day period from 2015 to 2018, with this trend on the rise.
Anxiety: The CDC reports that 12.5% of U.S. adults experience regular feelings of worry, nervousness, or anxiety.